These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9921114)

  • 1. Influence of a carrier and basis upon liberation of chlorpropamide from rectal suppositories with an active substance in the dispersion system.
    Kosior A
    Acta Pol Pharm; 1998; 55(5):353-7. PubMed ID: 9921114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of hypoglycemic properties of rectal suppositories with chlorpropamide.
    Kosior A
    Acta Pol Pharm; 2002; 59(2):109-13. PubMed ID: 12365601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
    Regdon Géza JR; Schirm I; Pittmann A; Regdon G
    Acta Pharm Hung; 1995 Mar; 65(2):45-50. PubMed ID: 7793289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with the rectal use of a chemotherapeutic agent. 1. In vitro biopharmaceutical examinations; selection of the optimal vehicle].
    Regdon G; Erös I; Gombkötö Z; Németh J; Regdon G; Vernyik A; Sallai J
    Acta Pharm Hung; 1998 Jul; 68(4):224-8. PubMed ID: 9737023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formulation and analysis of suppositories containing papaverine hydrochloride. Part 2. In vitro membrane diffusion studies].
    Regdon G; Vastag T; Regdon G; Selmeczi B
    Acta Pharm Hung; 1991 Nov; 61(6):303-9. PubMed ID: 1785359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Formulation of diazepam suppositories, results of rheological and biopharmaceutical studies. 1. Rheological study of the used suppository bases].
    Erós I; Bácskay I; Regdon G; Selmeczi B
    Acta Pharm Hung; 1993 Sep; 63(5):267-75. PubMed ID: 8249611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
    Bećirević M; Petricić V
    Pharmazie; 1986 May; 41(5):338-40. PubMed ID: 3737665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Formulation and in vitro investigation of antibacterial vaginal suppositories. Part 1. Considerations in selecting the vehicle. Methods and results of the physical examination].
    Tariné Gombkötö Z; Regdon G; Regdon G; Selmeczi B
    Acta Pharm Hung; 1992 Nov; 62(6):295-301. PubMed ID: 1488915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G; Vágó I; Mándi E; Regdon G; Erós I
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
    Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
    Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the action of various factors on the liberation from suppositories (author's transl)].
    Bornschein M; Grohmann A; Voigt R
    Pharmazie; 1980 Dec; 35(12):772-6. PubMed ID: 7208579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro study of antibacterial vaginal suppositories.
    Regdon G; Gombkötö S; Regdon G; Selmeczi B
    Pharm Acta Helv; 1994 Dec; 69(3):141-8. PubMed ID: 7846083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of consistency in lipophilic bases of suppositories and of drug-containing suppositories. 1. Elasticity measurements].
    Regdon G; Mezey G; Sztankovánszky K
    Pharmazie; 1973 Jul; 28(7):461-4. PubMed ID: 4767495
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
    Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
    Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assay and stability of chlorpropamide in solid dispersion with urea.
    Ford JL; Stewart AF; Rubinstein MH
    J Pharm Pharmacol; 1979 Nov; 31(11):726-9. PubMed ID: 41900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.